Active substance

Haemagglutininum influenzae A (H1N1) (Virus souche A/Missouri/11/2025 (H1N1)-like: reassortant virus IVR-278 derived from A/Switzerland/6849/2025) + Haemagglutininum influenzae A (H3N2) (Virus souche A/Darwin/1454/2025 (H3N2)-like: reassortant virus SAN-049A derived from A/Michigan/105/2025) + Haemagglutininum influenzae B (Virus souche B/Tokyo/EIS13-175/2025-like: derived from B/Tokyo/EIS-175/2025 (Victoria lineage) + Wild type)

1 products from 1 companies contain this in Switzerland.

1 prescription only

Prescription only

Efluelda TIV 0.5 mLPrescription only Sanofi-Aventis (Suisse) SA · Haemagglutininum influenzae A (H1N1) (Virus souche A/Missouri/11/2025 (H1N1)-like: reassortant virus IVR-278 derived from A/Switzerland/6849/2025) + Haemagglutininum influenzae A (H3N2) (Virus souche A/Darwin/1454/2025 (H3N2)-like: reassortant virus SAN-049A derived from A/Michigan/105/2025) + Haemagglutininum influenzae B (Virus souche B/Tokyo/EIS13-175/2025-like: derived from B/Tokyo/EIS-175/2025 (Victoria lineage) + Wild type) · J07BB02

Same substance is not the same product. Strength, form, release mechanism and other ingredients all differ. Whether one can replace another is a decision for a pharmacist.